Respiratory rate‑oxygenation (ROX) index for predicting high-flow nasal cannula failure in patients with and without COVID-19 - 28/11/23
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Abstract |
Background |
The predictive value of the respiratory rate‑oxygenation (ROX) index for a high-flow nasal cannula (HFNC) in patients with COVID-19 with acute hypoxemic respiratory failure (AHRF) may differ from patients without COVID-19 with AHRF, but these patients have not yet been compared. We compared the diagnostic accuracy of the ROX index for HFNC failure in patients with AHRF with and without COVID-19 during acute emergency department (ED) visits.
Methods |
We performed a retrospective analysis of patients with AHRF treated with an HFNC in an ED between October 2020 and April 2022. The ROX index was calculated at 1, 2, 4, 6, 12, and 24 h after HFNC placement. The primary outcome was the failure of the HFNC, which was defined as the need for subsequent intubation or death within 72 h. A receiver operating characteristic (ROC) curve was used to evaluate discriminative power of the ROX index for HFNC failure.
Results |
Among 448 patients with AHRF treated with an HFNC in an ED, 78 (17.4%) patients were confirmed to have COVID-19. There was no significant difference in the HFNC failure rates between the non-COVID-19 and COVID-19 groups (29.5% vs. 33.3%, p = 0.498). The median ROX index was higher in the non-COVID-19 group than in the COVID-19 group at all time points. The prognostic power of the ROX index for HFNC failure as evaluated by the area under the ROC curve was generally higher in the COVID-19 group (0.73–0.83) than the non-COVID-19 group (0.62–0.75). The timing of the highest prognostic value of the ROX index for HFNC failure was at 4 h for the non-COVID-19 group, whereas in the COVID-19 group, its performance remained consistent from 1 h to 6 h. The optimal cutoff values were 6.48 and 5.79 for the non-COVID-19 and COVID-19 groups, respectively.
Conclusions |
The ROX index had an acceptable discriminative power for predicting HFNC failure in patients with AHRF with and without COVID-19 in the ED. However, the higher ROX index thresholds than those in previous publications involving intensive care unit (ICU) patients suggest the need for careful monitoring and establishment of a new threshold for patients admitted outside the ICU.
Il testo completo di questo articolo è disponibile in PDF.Keywords : COVID-19, High-flow nasal cannula, Acute hypoxemic respiratory failure, ROX index, Endotracheal intubation, Discriminative power
Mappa
Vol 75
P. 53-58 - gennaio 2024 Ritorno al numero
Articolo precedente
- Prediction of the neurological outcomes post-cardiac arrest: A prospective validation of the CAST and rCAST
- Kazuya Kikutani, Mitsuaki Nishikimi, Kota Matsui, Atsushi Sakurai, Kei Hayashida, Nobuya Kitamura, Takashi Tagami, Taka-aki Nakada, Shigeyuki Matsui, Shinichiro Ohshimo, Nobuaki Shime, on behalf of the SOS-KANTO 2017 Study Group
- Is the shock index correlated with blood loss? An experimental study on a controlled hemorrhagic shock model in piglets
- Thomas Sanchez, Fabien Coisy, Laura Grau-Mercier, Céline Occelli, Florian Ajavon, Pierre-Géraud Claret, Thibaut Markarian, Xavier Bobbia
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.